In Serous Ovarian Neoplasms the Frequency of Ki-ras Mutations Correlates with Their Malignant Potential
Overview
Molecular Biology
Pathology
Authors
Affiliations
We analysed 44 tissue samples from serous ovarian neoplasms of different malignant potential for Ki-ras mutations by denaturing gradient gel electrophoresis (DGGE) and direct sequencing after microdissection. Point mutations at codon 12 were found in 7 of 20 tumours of low malignant potential (LMP) (35%) and in 2 of 6 well-differentiated carcinomas (33%). In contrast, no mutations were detected in the 11 poorly differentiated ovarian carcinoma samples or in the 7 serous cystadenomas. The frequency of Ki-ras mutations in serous ovarian tumours seems to correlate with the malignant potential of the neoplasms. The data favour the hypothesis of a de novo development of poorly differentiated ovarian carcinomas and do not support an evolution from LMP tumours or well-differentiated carcinomas.
De Thaye E, Van de Vijver K, Van der Meulen J, Taminau J, Wagemans G, Denys H Sci Rep. 2020; 10(1):6688.
PMID: 32317693 PMC: 7174384. DOI: 10.1038/s41598-020-63738-6.
Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer.
Van Nieuwenhuysen E, Busschaert P, Laenen A, Moerman P, Han S, Neven P Neoplasia. 2019; 21(6):582-590.
PMID: 31054497 PMC: 6500912. DOI: 10.1016/j.neo.2019.03.014.
Tubal Origin of "Ovarian" Low-Grade Serous Carcinoma: A Gene Expression Profile Study.
Wang Y, Hong S, Mu J, Wang Y, Lea J, Kong B J Oncol. 2019; 2019:8659754.
PMID: 30949203 PMC: 6425354. DOI: 10.1155/2019/8659754.
The molecular pathology of ovarian serous borderline tumors.
Malpica A, Wong K Ann Oncol. 2016; 27 Suppl 1:i16-i19.
PMID: 27141064 PMC: 4852276. DOI: 10.1093/annonc/mdw089.
Tubal origin of ovarian low-grade serous carcinoma.
Chen C, Li J, Yao G, Chambers S, Zheng W Am J Clin Exp Obstet Gynecol. 2014; 1(1):13-36.
PMID: 25346935 PMC: 4205570.